Victoria Sherry,

DNP, CRNP, ANP-BC, AOCNP

Victoria Sherry,

DNP, CRNP, ANP-BC, AOCNP

Adult Oncology Nurse Practitioner, Penn Medicine Abramson Cancer Center, University of Pennsylvania School of Nursing

Victoria Sherry,

DNP, CRNP, ANP-BC, AOCNP
Adult Oncology Nurse Practitioner, Penn Medicine Abramson Cancer Center, University of Pennsylvania School of Nursing

Victoria Sherry holds a dual appointment at the Abramson Cancer Center Penn Medicine as an adult oncology nurse practitioner for thoracic malignancies and as an advanced senior lecturer in the school of nursing, where she teaches both undergraduate and graduate students. She completed her Masters in Nursing at the University of Pennsylvania and her Doctor of Nursing Practice at Duke University. Victoria is a member of the Oncology Nursing Society (ONS) and the Philadelphia Area Chapter of the ONS, as well as the Xi Chapter of Sigma Theta Tau, the honor society of nursing. Throughout her career, Victoria has developed numerous presentations, webinars, and podcasts focused on the clinical knowledge of treatments and supportive care for patients with lung cancer. She is widely published on multiple topics, with a focus on symptom and toxicity management in lung cancer.

Victoria's Shared Resources

FDA Approves Amgen’s IMDELLTRA™ for Advanced Small Cell Lung Cancer

Amgen announced that the FDA has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung...
CURATED BY:
Victoria Sherry,
DNP, CRNP, ANP-BC, AOCNP

Gilead’s Phase 3 EVOKE-01 Study on Trodelvy® Fails to Meet Primary Endpoint in Metastatic NSCLC

The phase 3 EVOKE-01 study by Gilead Sciences, Inc., evaluating Trodelvy® (sacituzumab govitecan-hziy; [SG]) against docetaxel in patients with metastatic...
CURATED BY:
Victoria Sherry,
DNP, CRNP, ANP-BC, AOCNP

New Blood-Based Test Shows Promise as a More Accurate Predictor of Immunotherapy Response in Late-Stage Cancers

Researchers of a study looked at the challenges in predicting the response to immunotherapies in late-stage cancers, particularly in the...
CURATED BY:
Victoria Sherry,
DNP, CRNP, ANP-BC, AOCNP

Study Reveals Shifting Trends in US Cancer Incidence and Mortality

In a study, researchers reviewed American Cancer Society data on cancer cases and deaths in the United States. The study...
CURATED BY:
Victoria Sherry,
DNP, CRNP, ANP-BC, AOCNP

Study Shows Link Between Incidental Lung CT Findings and Respiratory Disease Mortality

Researchers of a study analyzed data from the National Lung Screening Trial to investigate the connection between incidental respiratory findings...
CURATED BY:
Victoria Sherry,
DNP, CRNP, ANP-BC, AOCNP

Osimertinib Shows Promise in Treating Uncommon EGFR Mutations in Stage IV Non-Small Cell Lung Cancer

Researchers of a recent study evaluated the efficacy and safety of osimertinib in patients with stage IV non-small-cell lung cancer...
CURATED BY:
Victoria Sherry,
DNP, CRNP, ANP-BC, AOCNP
Share